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Summary  Molecular  biological  search  and  identiﬁcation  of  cancer  have  a  variety  of  clinical
signiﬁcance.  Microarray,  proteomics  and  metabolome  analyses  are  powerful  analytical  methods
for  rapid  screening  of  tumor  markers.  From  the  results,  it  was  revealed  that  a  number  of  genes
are  speciﬁcally  expressed  in  oral  cancers.  From  the  results  of  CAN  and  LOH  analyses  of  the  entire
genome,  three  candidate  gene  loci  (D1S1189,  D1S2151,  D1S2595)  were  identiﬁed  on  1q31.1
region.  From  the  results  obtained  by  using  array  CGH,  ampliﬁcation  of  the  11q13  regions  was
observed  in  30%  of  the  group  with  lymph  node  metastasis,  and  a  numbers  of  genes  were  located
in  the  11q13  regions,  in  which  increase  of  the  copy  number  was  observed  in  only  the  group  with
lymph  node  metastasis.  From  the  results  of  proteomics  analysis,  three  protein  spots,  in  which
expression  increased  in  a  common  manner  with  a  oral  cancer  cell  line,  as  well  as  27  spots,  in
which  expression  decreased  in  a  common  manner  with  a  oral  cancer  cell  line,  were  identiﬁed
from  these  cataloged  spots.  Seven  spots  of  proteins  that  are  speciﬁcally  expressed  in  the  wholeSingle  nucleotide
polymorphism;
Comparative  genomic
saliva  of  oral  cancer  patients  before  a  surgery  and  not  detected  from  the  whole  saliva  after  the
surgery  or  the  whole  saliva  of  a  healthy  subject  were  selected.  In  the  metabolome  analysis,
peaks  of  250  of  the  major  metabolic  substances  (136  cations,  114  anions)  were  detected.
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n. Introduction
uperﬁcial  oral  cancers  may  be  become  conscious  or
etected in  relatively  early  stage  and  result  in  good  out-
ome; however,  quite  a  number  of  superﬁcial  oral  cancer
ases have  resulted  in  poor  outcome  depending  on  the
ites and  proliferation  manners.  Major  goals  of  the  modern
edicine include  to  reduce  deaths  caused  by  cancers  (sec-
ndary prevention),  and  then  to  reduce  the  development  of
ancers (primary  prevention).  To  achieve  these  goals,  it  is
trongly required  to  clarify  the  pathogenesis  of  cancers  and
he mechanism  of  the  cancer  development  and  to  establish
revention methods  based  on  these  results,  in  addition  to
rogress in  treatment  approaches.
Understanding  of  oral  cancers  from  the  molecular  bio-
ogical aspect  has  a  signiﬁcance  as  the  foundation  of  the
earch for  effective  treatment  and  preventive  approaches.
his article  gives  an  explanation  for  the  outcomes  of  the
nalysis of  data  obtained  by  molecular  biological  studies  of
ral cancer  conducted  in  our  laboratory  since  1998.
. Molecular biological studies of oral cancer
n our department
.1.  Analyses  of  the  copy  number  in  the  entire
enome and  loss  of  heterozygosity  using
igh-density single  nucleotide  polymorphism  (SNP)
enotyping
earch  for  the  mechanism  of  cancer  development  started
rom detection  of  genetic  changes  that  cause  uncontrollabil-
ty of  cells,  including  copy  number  abnormalities  (CANs)  and
oss of  heterozygosity  (LOH),  as  well  as  unregulated  growth.
hese chances  are  caused  by  activation  of  oncogenes,
hich stimulate  oncogenic  transformation,  or  inactivation
f tumor  suppressor  genes  in  many  cancers.  We  have  stud-
ed losses  on  chromosomes  2,  3  and  21  associated  with
he development  process  of  oral  squamous  cell  carcinoma
OSCC) using  LOH  method  to  analyze  allelic  imbalance  up
o the  present  [1—11].  From  the  results,  common  deleted
egions, including  two  regions  on  2q,  three  regions  on  3p  and
our regions  on  21q,  were  identiﬁed  among  OSCC  patients,
nd demonstrated  that  unknown  tumor  suppressor  genes
nvolved in  the  development  of  oral  cancer  exist  on  these
hromosomal loci  (Fig.  1).
Recently,  high-density  oligonucleotide  arrays  (Affyme-
rix, GeneChip®Mapping  10K  Array)  for  a  large  scale  single
ucleotide polymorphism  (SNP)  typing  have  developed.  This
i
w
o
rrray  allows  comprehensive  analysis  of  various  changes  in
ancer cell  genome  that  occurred  on  the  entire  chromo-
omes. Gene  sequences  of  individual  humans  are  the  same
p to  99.9%,  and  remaining  0.1%  of  sequences  is  different.
his difference  is  called  single  nucleotide  polymorphisms
SNPs), and  caused  by  mutations,  in  which  only  single  base
s substituted  in  DNA  sequences.  SNPs  are  valuable  infor-
ation to  clarify  patterns  of  genetic  variations  or  genetic
ifferences related  to  the  oncogenesis.  It  is  estimated  that
he human  genome  contains  10  million  SNPs.  This  means  SNP
ppears at  a  rate  of  once  every  300  bps.  Average  interval  of
NP probes  for  GeneChip®Mapping  10K  Array  is  210  kb,  which
an measure  10,204  SNPs.  This  enables  to  detect  changes  in
he copy  number  of  chromosomes  with  an  extremely  high
esolution as  compared  with  existing  comparative  genomic
ybridization (CGH)  method.  From  the  results  of  CAN  and
OH analyses  of  the  entire  genome,  three  candidate  gene
oci (D1S1189,  D1S2151,  D1S2595)  were  identiﬁed  on  1q31.1
egion [12,13].
.2.  Comprehensive  analysis  using  comparative
enomic hybridization  (CGH)  method
omprehensive  search  of  the  entire  genome  was  conducted
o ﬁnd  molecular  markers  for  cervical  lymph  node  metastasis
sing array-based  CGH,  and  efﬁcacy  of  clinical  application  of
he detected  molecular  markers  was  examined.  Subjected
pecimens were  obtained  from  54  patients  with  OSCC  who
nderwent surgical  procedure  (22  cases  with  lymph  node
etastasis, 32  cases  without  lymph  node  metastasis).  First,
omprehensive analysis  of  the  entire  genome  of  20  cases
f these  specimens  (10  cases  with  lymph  node  metastasis,
0 cases  without  lymph  node  metastasis)  was  conducted
sing array  CGH.  Real-time  QPCR  was  conducted  for  all  54
atients using  the  regions  extracted  from  the  comprehensive
nalysis. The  results  obtained  from  array  CGH  of  chromo-
omes 1—12  indicated  that  there  was  a  bias  of  the  ratio
etween the  groups  with  and  without  lymph  node  metasta-
is in  the  long  arm  region  of  chromosome  11  [14].  No  regions
ndicating such  bias  between  two  groups  were  detected
n chromosomes  13—22.  Increase  of  the  copy  number  and
eleted regions  in  chromosome  11  for  individual  patients
re shown  in  Fig.  2.  Ampliﬁcation  of  the  11q13  regions  was
bserved in  30%  of  the  group  with  lymph  node  metastasis.  A
umbers of  genes  are  located  in  the  11q13  regions,  in  which
ncrease of  the  copy  number  was  observed  in  only  the  group
ith lymph  node  metastasis.  From  the  results  of  an  analysis
f copy  number  variation  for  this  region  of  54  cases  using
eal-time QPCR,  it  was  suggested  that  these  regions  might
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tFigure  1  Tumor  suppressor  gene  loci  of  oral  cancer  in  our  d
regions  on  3p  and  4  regions  on  21q,  were  identiﬁed  among  OSC
be  available  as  new  predictive  markers  for  cervical  lymph
node metastasis  (Fig.  2)  [15].
2.3.  Proteomics  analysis  of  proteins  related  to  oral
cancer
As  the  next  step  after  human  complete  genome  sequencing,
proteomics studies  clarifying  the  relationship  between  gene
products and  biological  functions  attract  growing  interest
[16]. Proteomics  understands  the  meaning  of  gene  infor-
mation at  the  protein  level,  which  is  the  ﬁnal  product  of
the genes,  and  provides  information  essential  for  simula-
tion of  vital  activities  of  cells.  We  identiﬁed  and  analyzed
proteins related  to  oral  cancer  by  applying  this  proteomics
to oral  cancer  cells.  More  speciﬁcally,  we  conducted  com-
prehensive protein  expression  analysis  in  a  cell  line  derived
from OSCC  and  epidermal  keratinocytes  derived  from  nor-
mal oral  mucosa  using  two-dimensional  electrophoresis  and
MALDI-TOF mass  spectrometry.  The  listed  selected  gene
products were  also  analyzed  at  RNA  level  and  DNA  level.
Gene function  analyses  using  gene  transfer  techniques  were
also  conducted  at  the  same  time  to  determine  the  function
of proteins.
Two-dimensional electrophoresis  is  a  method  to  sepa-
rate proteins  with  two  times  of  electrophoresis:  isoelectric
focusing, which  separates  proteins  based  on  differences
in pH  that  the  electric  charge  of  molecule  become  neu-
tral, as  the  ﬁrst  dimension  separation,  and  SDS-PAGE,  which
separates proteins  according  to  difference  in  the  molecular
weight, as  the  second  dimension  separation.  After  the  two-
dimensional electrophoresis,  the  gels  are  stained  by  silver
c
a
s
otment.  Common  deleted  regions,  including  2  regions  on  2q,  3
ients.
taining  method,  and  then,  the  detected  individual  proteins
ere cataloged  as  protein  spots  on  the  gels  (Fig.  3).
From  the  results,  three  protein  spots,  in  which  expres-
ion increased  in  a  common  manner  with  a  oral  cancer  cell
ine, as  well  as  27  spots,  in  which  expression  decreased  in  a
ommon manner  with  a  oral  cancer  cell  line,  were  identiﬁed
rom these  cataloged  spots.  Of  these  protein  spots,  ﬁve  spots
ith large  expression  difference  were  analyzed  with  MALDI-
OF MS.  Protein  spots,  in  which  expression  is  decreased  in
ral cancer  cells  speciﬁcally,  were  cut  out  from  gels,  and
nalyzed with  MALDI-TOF  MS.  From  the  results,  ubiquitous
itochondrial creatine  kinase  (CKMT1)  was  identiﬁed  as  a
umor-suppressor functional  protein  with  decreased  expres-
ion speciﬁcally  in  oral  cancer  cells  (Fig.  4).  In  addition,
t was  suggested  that  the  decreased  expression  of  CKMT1
s often  observed  in  OSCC  and  the  decreased  expression
s under  epigenetic  control.  Furthermore,  it  was  presumed
hat CKMT1  might  induce  apoptosis  of  OSCC  through  the
echanism such  as  permeability  transition  pore  (PTP)  mech-
nism in  mitochondria  (Fig.  5)  [16].
.4.  Oral  cancer  screening  using  salivary  proteins
e  examined  a  possibility  of  oral  cancer  screening  using  the
hole saliva  as  samples  that  can  be  collected  easily,  non-
nvasively, and  repeatedly.  It  has  been  previously  reported
hat IL-6  and  IL-8  in  the  saliva  speciﬁcally  increase  in  oral
ancer patients  [17].  In  addition,  comprehensive  proteomics
nalysis of  changes  in  protein  expression  in  the  whole
aliva indicated  that  some  proteins  speciﬁcally  appeared
r are  deleted  in  oral  cancer  [18].  More  speciﬁcally,  we
28  N.  Yamamoto  et  al.
Figure  2  Analysis  of  cervical  lymph  node  metastasis  molecular  marker  using  array  CGH.  Ampliﬁcation  of  the  11q13  regions  was
observed  in  30%  of  the  group  with  lymph  node  metastasis.  A  number  of  genes  are  located  in  the  11q13  regions,  in  which  increase
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(f  the  copy  number  was  observed  in  only  the  group  with  lymph
dentiﬁed  and  analyzed  proteins  related  to  oral  cancers,
hich can  be  new  biomarkers  and  molecular  targets  that
peciﬁcally change  in  the  saliva  of  oral  cancer  patients,
sing two-dimensional  electrophoresis  and  MALDI-TOF  mass
pectrometry.  From  the  results  of  image  analysis,  about
00—1200 protein  spots  were  detected  in  each  proteome.
hen, 132—296  protein  spots  that  are  speciﬁcally  expressed
n the  whole  saliva  of  oral  cancer  patients  and  disappeared
fter a  surgery  were  found.  Of  these  spots,  the  spots  that
ere expressed  in  all  samples  in  common  were  18  spots.
n addition,  283—572  spots  of  proteins  that  are  speciﬁcally
xpressed in  the  whole  saliva  of  oral  cancer  patients  and  not
etected  from  the  whole  saliva  of  a  healthy  subject  were
ound. Of  these  spots,  protein  spots  that  were  expressed  in
ll samples  in  common  were  39  spots  (Fig.  6).  In  the  end,
even spots  of  proteins  that  are  speciﬁcally  expressed  in
he whole  saliva  of  oral  cancer  patients  before  a  surgery
nd not  detected  from  the  whole  saliva  after  the  surgery
r the  whole  saliva  of  a  healthy  subject  were  selected
18—20].
t
c
t
c metastasis.
We  are  going  to  identify  these  proteins,  conﬁrm  the
ocalization of  these  proteins  in  tissues,  and  examine  the
ccuracy as  biomarkers  for  oral  cancer  in  the  future.
.5.  Metabolome  analysis  of  oral  cancer
 movement  to  apply  metabolome  analysis  to  search  for
iomarkers and  in  the  diagnosis  of  diseases  has  been
arkedly activated.  Metabolome  means  a  set  of  small
olecule metabolites  contained  in  a  biological  ﬂuid,  tis-
ue or  cell  at  a  certain  point  in  time.  Metabolome
s a comprehensive,  qualitative  and  quantitative  analy-
is of  these  metabolites,  and  is  conducted  using  mainly
apillary electrophoresis  time-of-ﬂight  mass  spectrometry
CE-TOFMS). Especially,  metabolome  analysis  attracts  atten-
ion for  biomarker  search  because  it  is  expected  that  cancer
ells undergo  changes  in  the  metabolism  caused  by  pro-
eins and  enzymes  with  expression  abnormality,  and  these
hanges in  the  metabolism  shift  to  cancer  speciﬁc  metabolic
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Figure  3  Proteomics  analysis  using  two-dimensional  electrophoresis.  NOK  and  Ca9-22  show  normal  cells  and  oral  cancer  cells,
respectively.  Expression  decreased  proteins  were  identiﬁed.
Figure  4  Protein  identiﬁcation  by  peptide-mass  ﬁngerprinting.  Expression  decreased  proteins  are  conﬁrmed  by  two-dimensional
electrophoresis (upper),  and  show  amino  acid  sequence  (lower).
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Figure  5  (a)  Protein  identiﬁcation  by  peptide-mass  ﬁngerprinting.  (b)  Immunoﬂuorescence  analyses  of  CKMT1.
Figure  6  Proteome  analysis  using  saliva.  283—572  spots  of  proteins  that  are  speciﬁcally  expressed  in  the  whole  saliva  of  oral
cancer patients  and  not  detected  from  the  whole  saliva  of  healthy  subject  were  found.
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Figure  7  Metabolic  pathway  of  OSCC  cell  line  (SAS).  The  ﬁgure  shows  HaCaT  (control)  (blue)  and  a  relative  area  level  of  SAS  (oral
d
n
t
m
n
wcancer  cells)  (red).
pattern,  and  then  such  shift  is  reﬂected  by  the  blood
and urine.  Analysis  approaches  targeting  macromolecules
including transcriptome  analysis,  which  comprehensively
determine quantity  of  mRNA,  and  metabolome  analysis
that we  used,  which  comprehensively  analyzes  expressed
proteins, cannot  detect  mRNA  or  protein  from  blood  and
urine samples  frequently  used  for  examination  purpose.
Accordingly, there  are  some  opinions  pointed  out  that
these analysis  approaches  have  produced  results  less  than
originally expected  as  biomarkers  for  early  detection  and
c
m
cetermination  of  the  degree  of  progression  and  prog-
osis. Advantages  of  metabolome  analysis  include  that
his approach  is  targeting  small  molecules,  therefore  the
olecules can  be  detected  from  biological  ﬂuids;  that  the
umber of  the  targeted  metabolites  is  small  as  compared
ith genomics,  transcriptome  and  proteomics;  and  that
ancer related  molecules  can  be  easily  detected  because
etabolites are  the  ﬁnal  phenotypes.
Then,  detection  of  metabolic  products  speciﬁc  to  can-
er cells  secreted  into  culture  medium  of  a  cell  line  derived
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rom  OSCC  were  attempted.  The  cell  line  derived  from  OSCC
SAS), and  epidermal  keratinocyte  (HaCaT),  which  is  a  con-
rol, were  used.  Measurement  in  a  cation  mode  and  anion
ode were  conducted  using  CE-TOFMS.  A  principal  com-
onent analysis  (PCA)  was  implemented  with  a  software,
ampleStat version  3.14.  Furthermore,  hierarchical  cluster
nalysis (HCA)  and  drawing  of  heatmap  expression  were
mplemented using  a  software,  PeakStat  version  3.18.
In  the  metabolome  analysis,  peaks  of  250  of  the
ajor metabolic  substances  (136  cations,  114  anions)  were
etected.  These  substances  were  mapped  in  the  glycolytic
ystem/gluconeogenesis,  pentose  phosphate  pathway,  citric
cid  cycle,  urea  cycle,  purine  metabolic  pathway,  pyrimi-
ine metabolic  pathway,  nicotinic  acid  metabolic  pathway,
icotinamide metabolic  pathway,  and  various  amino  acid
etabolic pathways.  The  calculated  quantitative  values  and
ajor metabolic  pathways  are  shown  in  Fig.  7.
Transcriptome  analysis,  which  determines  the  quantity
f mRNA  for  macromolecules,  and  proteome  analysis,  which
etermines the  quantity  of  proteins  were  of  great  assis-
ance to  clarify  the  mechanism  of  disease  development
t the  molecular  level;  however,  these  analyses  cannot
etect mRNA  or  protein  from  blood  and  urine  samples  used
or examination  purpose.  Accordingly,  metabolome  analy-
is targeting  small  molecules  would  be  useful  for  discovery
f biomarkers  for  the  diagnostic  purpose.  Therefore,  it
as suggested  that  there  is  a  possibility  that  these  results
an contribute  to  establishment  of  less  invasive  diagnostic
echniques using  biological  ﬂuids  if  low  molecular  weight
ompounds listed  in  this  study  can  be  detected  from  various
iological ﬂuids  from  cancer  patients.
. Conclusions
(i)  Deletions  on  chromosomes  2,  3  and  21  were  detected
with the  course  of  oral  cancer  development,  and  com-
mon  deletion  regions  were  identiﬁed.  Furthermore,  CAN
and  LOH  on  the  whole-genome  were  examined,  and  sev-
eral  candidate  genes  were  shown.
ii) Copy  number  ampliﬁcation  in  the  chromosome  11q13
region  was  detected  in  only  30%  of  the  group  of  patients
with  metastasis  by  array  CGH  method  conducted  in  20
patients  with  oral  squamous  cell  cancer.  For  11  genes  in
this  region,  the  ampliﬁed  chromosome  11q13  region  was
divided  in  two  groups  and  identiﬁed  novel  breakpoints,
Core  1  including  TPCN2  and  MYEOV,  and  Core  2  including
from CCND1  to  CTTN  based  on  the  correlation  with  the
copy  numbers.  It  is  suggested  that  variation  of  the  copy
number  of  Core  1  and  Core  2  can  be  novel  predictive
markers for  cervical  lymph  node  metastasis.
ii) Based  on  the  proteomics  analysis  of  culture  medium  of
oral  squamous  cell  cancer  cells,  3  proteins  derived  from
human  that  shows  expression  abnormality  in  common
were listed.
iv)  From  the  results  of  proteomics  analysis  of  saliva,  1200
proteins  were  detected.  Of  these  proteins,  there  were
10  target  proteins  that  were  speciﬁcally  expressed  in
common  in  oral  cancer  patients  before  surgery,  and  Eno-
lase  1  was  identiﬁed  as  a  candidate  protein  from  human
from  these  proteins.N.  Yamamoto  et  al.
v) Metabolomic  analysis  of  cancer  cell  speciﬁc  metabolic
products excreted  into  culture  medium  of  a  cell  line
derived  from  oral  squamous  cell  cancer  was  conducted
and  250  of  the  major  metabolite  peaks  (136  cations  and
114  anions)  were  detected.
Most of  the  oral  cancers  can  be  directly  observed  and
elt on  palpation.  This  is  clinically  a  lucky  circumstance,
nd a  high  cancer  control  rate  should  be  obtained  under
uch conditions.  However,  unfortunately,  both  the  morbidity
nd mortality  rates  of  oral  cancers  are  going  in  increas-
ng in  Japan.  As  a  radical  solution  to  this  problem,  from
he research  aspect,  it  is  also  important  to  conduct  extrac-
ion of  high-risk  groups,  molecular  biological  identiﬁcation
f oral  cancer  cells,  and  evaluation  of  prognosis  using  gene
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